Despite these limitations though, our analyses document that the “kick and kill” strategy used in BCN02 left specific marks on inflammatory and neurological plasma proteomes and allowed us to identify soluble CD33 as a novel biomarker of poor virus control (both, during the ART interruption phase of BCN02 and in natural HIV infection). The gene discussed is CD33; the disease is HIV infectious disease.